Related Experiment Video

Updated: Jul 8, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Child myocardial infarction and follow-up outcome after revascularization

Mohammad A Rahman1, Habib Chaudhury, Nurul Aga

  • 1National Institute of Cardiovascular Diseases, Department of Cardiology, Sher-ebangla Nagar, Dhaka, Bangladesh. afzalur@dhaka.net

The Journal of Invasive Cardiology
|January 5, 2008
PubMed

Insights

This study details the rare case of percutaneous coronary intervention (PCI) for atherosclerotic heart disease in the youngest patient on record. The child experienced an excellent outcome following the procedure, demonstrating successful treatment for pediatric coronary artery disease.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Atherosclerosis Research

Background:

  • Myocardial infarction and revascularization via percutaneous coronary intervention (PCI) are uncommon in pediatric populations.
  • Existing cases are typically linked to secondary causes, not primary atherosclerotic disease.

Observation:

  • This report presents a rare case of atherosclerotic coronary heart disease in the youngest patient requiring revascularization.
  • The patient underwent successful percutaneous coronary intervention (PCI) in a real-world clinical setting.

Findings:

  • The youngest patient with atherosclerotic coronary heart disease successfully underwent PCI.
  • The patient achieved an excellent clinical outcome with over 30 months of follow-up post-PCI.

Implications:

  • This case highlights the possibility of primary atherosclerotic coronary heart disease in very young patients.
  • Successful PCI in such young patients suggests potential for effective intervention and long-term management.
  • Further research into pediatric atherosclerosis and its treatment is warranted.

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...